FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roslyn Cassidy

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Brian D Green; Katharine V Hand; Janette E Dougan; Bronagh M McDonnell; Roslyn S Cassidy; David J Grieve
GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.
Roslyn S Cassidy; Nigel Irwin; Peter R Flatt
Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
Paula L McClean; Nigel Irwin; Roslyn S Cassidy; Jens J Holst; Victor A Gault; Peter R Flatt
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roslyn Cassidy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Brian D Green; Katharine V Hand; Janette E Dougan; Bronagh M McDonnell; Roslyn S Cassidy; David J Grieve
GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.
Archives of biochemistry and biophysics 2008;478(2):136-42.
2008: Roslyn S Cassidy; Nigel Irwin; Peter R Flatt
Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
Biological chemistry 2008;389(2):189-93.
2007: Paula L McClean; Nigel Irwin; Roslyn S Cassidy; Jens J Holst; Victor A Gault; Peter R Flatt
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
American journal of physiology. Endocrinology and metabolism 2007;293(6):E1746-55.
2007: Nigel Irwin; Paula L McClean; Roslyn S Cassidy; Finbarr P M O'Harte; Brian D Green; Victor A Gault; Patrick Harriott; Peter R Flatt
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide.
Diabetes/metabolism research and reviews 2007;23(7):572-9.
2007: Victor A Gault; Paula L McClean; Roslyn S Cassidy; Nigel Irwin; Peter R Flatt
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Diabetologia 2007;50(8):1752-62.
2006: Brian D Green; Nigel Irwin; Roslyn S Cassidy; Victor A Gault; Peter R Flatt
Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
Peptides 2006;27(9):2343-9.
2006: Nigel Irwin; Brian D Green; Victor A Gault; Roslyn S Cassidy; Finbarr P M O'Harte; Patrick Harriott; Peter R Flatt
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice.
Peptides 2006;27(4):893-900.